BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26801089)

  • 1. Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.
    Johnson ME; Grassetti AV; Taroni JN; Lyons SM; Schweppe D; Gordon JK; Spiera RF; Lafyatis R; Anderson PJ; Gerber SA; Whitfield ML
    Arthritis Res Ther; 2016 Jan; 18():27. PubMed ID: 26801089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief Report: Anti-Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis.
    Betteridge ZE; Woodhead F; Lu H; Shaddick G; Bunn CC; Denton CP; Abraham DJ; du Bois RM; Lewis M; Wells AU; McHugh NJ
    Arthritis Rheumatol; 2016 Nov; 68(11):2778-2783. PubMed ID: 27273608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
    Harvey G; Black C; Maddison P; McHugh N
    J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
    Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
    Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogenous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis.
    Stanek D; Vencovský J; Kafková J; Raska I
    Arthritis Rheum; 1997 Dec; 40(12):2172-7. PubMed ID: 9416854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.
    Song G; Hu C; Zhu H; Wang L; Zhang F; Li Y; Wu L
    J Rheumatol; 2013 Apr; 40(4):461-8. PubMed ID: 23418382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis.
    Bussone G; Dib H; Tamby MC; Broussard C; Federici C; Woimant G; Camoin L; Guillevin L; Mouthon L
    Arthritis Res Ther; 2011 May; 13(3):R74. PubMed ID: 21569507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-related autoantibody profile in patients with systemic sclerosis.
    Liaskos C; Marou E; Simopoulou T; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
    Autoimmunity; 2017 Nov; 50(7):414-421. PubMed ID: 28749191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-centromere antibodies target centromere-kinetochore macrocomplex: a comprehensive autoantigen profiling.
    Kajio N; Takeshita M; Suzuki K; Kaneda Y; Yamane H; Ikeura K; Sato H; Kato S; Shimizu H; Tsunoda K; Takeuchi T
    Ann Rheum Dis; 2021 May; 80(5):651-659. PubMed ID: 33208344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics characterization of CENP-B epitope in Moroccan scleroderma patients with anti-centromere autoantibodies.
    Zian Z; Bennani Mechita M; Hamdouch K; Maamar M; Barakat A; Ghailani Nourouti N; El Aouad R; Valdivia MM; Arji N
    Immunol Lett; 2020 May; 221():1-5. PubMed ID: 32057908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
    Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
    J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis.
    Vulsteke JB; Smith V; Bonroy C; Derua R; Blockmans D; De Haes P; Vanderschueren S; Lenaerts JL; Claeys KG; Wuyts WA; Verschueren P; Vanhandsaeme G; Piette Y; De Langhe E; Bossuyt X
    J Autoimmun; 2023 Feb; 135():102988. PubMed ID: 36634459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.
    Perosa F; Favoino E; Favia IE; Vettori S; Prete M; Corrado A; Cantatore FP; Valentini G
    Medicine (Baltimore); 2016 Jun; 95(25):e3931. PubMed ID: 27336883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
    Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
    J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases.
    Kuwana M; Kimura K; Hirakata M; Kawakami Y; Ikeda Y
    Ann Rheum Dis; 2002 Sep; 61(9):842-6. PubMed ID: 12176814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
    Chang WS; Schollum J; White DH; Solanki KK
    Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
    Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
    Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centrosome proteins: a major class of autoantigens in scleroderma.
    Gavanescu I; Vazquez-Abad D; McCauley J; Senecal JL; Doxsey S
    J Clin Immunol; 1999 May; 19(3):166-71. PubMed ID: 10404401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.